Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemoradiation with Cisplatin, 5FU, Interferon, and Gemcitabine for Pancreatic Cancer
NCT00660270Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- May 2002
- Primary completion
- Nov 2006
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, fluorouracil, interferon alfa, gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by Washington University School of Medicine. Started May 2002; status: completed.
02
Drugs
cisplatinfluorouracilinterferon alfagemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00660270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660270.